Consequently, it is plausible that different HDAC inhibitors modulate ferroptosis and disulfidptosis via distinct signaling pathways, even though other HDAC inhibitors apart from VPA may influence the sensitivity of HCC cells to ferroptosis or disulfidptosis. The gene discussed is HDAC9; the disease is hepatocellular carcinoma.